Search clinical trials for: Ramipril tablet

Total 7450 results

Gulhane School of Medicine

Completed

FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients

Diabetic Nephropathy | Proteinuria | Chronic Kidney Disease

Turkey
Sanofi

Completed

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

Glomerulonephritis

Hong Kong
University of Zurich
Sanofi

Completed

Ramipril in Rheumatoid Arthritis

Arthritis, Rheumatoid
University of Aarhus

Completed

The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin

Insulin Resistance | Hypopituitarism | Metabolism

Denmark
AstraZeneca
Parexel

Completed

A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Sickle Cell Disease

Germany
Xinhua Hospital, Shanghai Jiao Tong University...

Not yet recruiting

Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants

Alport Syndrome

China
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Active, not recruiting

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Glioblastoma | Chemoradiation | Cognitive Decline | Radiotherapy; Complications

United States, Guam
Ain Shams University

Completed

Ramipril in Pediatric Patients on Hemodialysis

Hemodialysis

Egypt
Xizang Haisco Pharmaceutical Co., Ltd

Not yet recruiting

A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.

Pruritus
BrodenBio Co., Ltd.

Recruiting

A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors

Advanced Solid Tumor

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Recruiting

A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis

Atopic Dermatitis

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Study of ICP-033 in Patients With Advanced Solid Tumors

Patients With Advanced Solid Tumors

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

Study of HA121-28 in Patients With Non-Small Cell Lung Cancer

NSCLC

China
VA Office of Research and Development
Baylor College of Medicine

Completed

Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients

COVID 19 | Rehabilitation | Inpatient | Hospitalized

United States
Pierre Fabre Medicament
Biotrial

Active, not recruiting

Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg Formulations

Melanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 Mutation

France
Grupo Cooperativo de Hemopatías Malignas

Completed

Treatment of SARS Caused by COVID-19 With Ruxolitinib

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
Jiangsu HengRui Medicine Co., Ltd.

Completed

The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy Subjects

Thrombus

China
Azienda Ospedaliero, Universitaria Pisana

Unknown

Baricitinib Compared to Standard Therapy in Patients With COVID-19 (BARICIVID-19)

Covid-19 | SARS-CoV 2 | SARS Pneumonia

Italy
University Hospital, Basel, Switzerland

Completed

Risk Assessment for Postoperative Delirium (RAPID)

Postoperative Delirium

Switzerland
Deciphera Pharmaceuticals LLC

Terminated

A Study of DCC-2701 in Participants With Advanced Solid Tumors

Metastatic Solid Tumors | Locally Advanced Tumors | Cancers With MET Genomic Alterations | Cancers With TRK Genomic Alterations

United States
University Hospital, Bonn

Completed

Tablet-based Patient Reported Outcome

Antineoplastic Agents

Germany
ALK-Abelló A/S

Completed

A Trial of the ALK Grass Tablet in Subjects With Hayfever

Allergy

Denmark
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects

Asthma

Denmark
ALK-Abelló A/S

Completed

Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets

Allergy

Spain
University Hospital, Basel, Switzerland

Completed

Palatability of an Oral Dispersible Tablet (ODT) Formulation in Children

Healthy

Switzerland
Sanofi

Completed

China Medical University Hospital (CMUH) Triapin Listing

Hypertension

Taiwan
AngioLab, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH

Nonalcoholic Steatohepatitis

Korea, Republic of
Pfizer

Terminated

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

Parkinson Disease

United States, France, Israel, Germany
Chong Kun Dang Pharmaceutical

Terminated

The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)

Hypertension

Korea, Republic of
Beijing Chest Hospital

Not yet recruiting

Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer

Malnutrition | Lung Cancer | Amino Acid Deficiency
Charite University, Berlin, Germany
Bayer

Not yet recruiting

Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome

Post-COVID ME/CFS

Germany
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Recruiting

A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis

Atopic Dermatitis

China
Shanghai Runshi Pharmaceutical Technology Co., Ltd
Jilin Provincial Tumor Hospital

Recruiting

A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors

Locally Advanced Unresectable Carcinoma

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Bioequivalence Study of Hetrombopag in Healthy Subjects

Sever Aplastic Anaemia

China
Badr University

Completed

Effect of Touch Screen Tablet on Fine Motor Functions

Hemiplegic Cerebral Palsy

Egypt
Pierre Fabre Medicament
Biotrial

Completed

Bioequivalence Binimetinib 3 x 15 mg and 45 mg Formulations

Melanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 Mutation

France
Peking University
The First Affiliated Hospital with Nanjing Medical University; Xiangya Hospital... and other collaborators

Active, not recruiting

Ripretinib in Chinese Patients With Advanced GIST: a Real World Study

Gastrointestinal Stromal Tumors

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects

Sever Aplastic Anaemia

China
LG Chem

Completed

Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects

Ulcerative Colitis

Korea, Republic of
University of California, San Francisco
Akili Interactive Labs, Inc.

Completed

Digital Cognition in Multiple Sclerosis (DigCog)

Multiple Sclerosis | Cognitive Decline

United States
Haihe Biopharma Co., Ltd.

Unknown

Study to Evaluate the Safety and Anti-tumor Activity of SCC244

Advanced Solid Tumor

China
Chen Xiangmei
Tianjin TongRenTang Group Co., Ltd.

Unknown

Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease

Chronic Kidney Disease

China
ALK-Abelló A/S

Completed

Safety of ALK Ragweed Tablet

Allergy

United States
Changchun GeneScience Pharmaceutical Co., Ltd.

Recruiting

A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Dose Escalation of GS1-144 Tablets and the Effects of Food on the Pharmacokinetics of GS1-144 in a Chinese Population

Healthy Volunteer | Vasomotor System; Labile

China
Tasly Pharmaceutical Group Co., Ltd

Not yet recruiting

Pharmacokinetic and Pharmacodynamic of Jia Shen Tablets in Chronic Heart Failure

Heart Failure

China
BrodenBio Co., Ltd.

Recruiting

A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors

Advanced Solid Tumor

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Recruiting

A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma

B-cell Lymphoma

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors

Advanced Endometrial Cancer, Cervical Cancer and Ovarian Cancer

China
The First Affiliated Hospital with Nanjing Medical...
Guangzhou Lupeng Pharmaceutical Company LTD.; Newave Pharmaceutical Inc

Recruiting

A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma

Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma

China
Haihe Biopharma Co., Ltd.

Recruiting

Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33

Advanced Solid Tumors

China

Search clinical trials for: Ramipril tablet

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations